Sinovac Biotech Ltd. (Nasdaq: SVA) plans to sell 8,650,000 common shares of the company in an underwritten public ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE